Capnia Inc Cmn Stk (CAPN) 1.00 $CAPN
Capnia to Present at Upcoming Investor Conferences
GlobeNewswire - Tue Sep 06, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at two upcoming investor conferences:
CAPNU: (), CAPN: 1.00 (unch)
Capnia Reports Second Quarter 2016 Financial Results
GlobeNewswire - Fri Aug 12, 3:05PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the second quarter ended June 30, 2016.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Exclusive Distribution Agreement for CoSense(R) End-Tidal Carbon Monoxide Monitor in India
GlobeNewswire - Tue Jun 07, 3:05PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has entered into an exclusive three-year distribution agreement with M/s.Healthware Private Limited (Healthware) for the sale of its CoSense End-Tidal Carbon Monoxide (ETCO) Monitor and Precision Sampling Sets in India.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Present at 2016 Marcum MicroCap Conference
GlobeNewswire - Wed May 25, 3:05PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the 2016 Marcum MicroCap Conference on Wednesday, June 1, 2016 at 11:30 AM ET at the Grand Hyatt in New York City.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Reports First Quarter 2016 Financial Results
GlobeNewswire - Tue May 10, 8:29AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the first quarter ended March 31, 2016.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Present at the Joseph Gunnar "Pioneers 2016" Conference
GlobeNewswire - Wed Apr 27, 3:06PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the Joseph Gunnar "Pioneers 2016" Conference on Thursday, May 5, 2016 at 1:00 PM ET at the New York Palace Hotel in New York City.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Presentation of CoSense(R) and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting
GlobeNewswire - Wed Apr 20, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced five posters and one oral presentation relating to scientific data for its CoSense ETCO monitor and other pipeline candidates at the 2016 Pediatric Academic Societies (PAS) Annual Meeting, being held April 30 - May 3, 2016 in Baltimore, MD.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Names Rajen Dalal to Board of Directors
GlobeNewswire - Mon Apr 18, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced the appointment of Rajen Dalal to the Company's Board of Directors. Mr. Dalal brings to Capnia extensive leadership experience, having served as a senior executive and board member for various medical device and point-of-care diagnostic companies during his career. He most recently served as the CEO of ReLIA Diagnostic Systems, Inc., a point-of-care diagnostics company, and served on ReLIA's board from 2006 until its sale to Yunfeng Capital in 2015, and was managing director of Synergenics LLC, the company's majority shareholder.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Present at the 18th Annual BIO CEO & Investor Conference
GlobeNewswire - Mon Feb 01, 3:04PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the 18 Annual BIO CEO & Investor Conference on Monday, February 8, 2016 at 8:00 AM ET at the Waldorf Astoria Hotel in New York City.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Signs Exclusive Nationwide Distribution Agreement for CoSense(R)
GlobeNewswire - Tue Jan 26, 3:01PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has entered into an exclusive distribution agreement with Bemes, Inc., a leading medical equipment Master Distributor, to market and distribute the CoSense End-Tidal Carbon Monoxide (ETCO) Monitor and Precision Sampling Sets (PSS).
CAPNU: (), CAPN: 1.00 (unch)
Capnia Regains Compliance With NASDAQ Listing Standards
GlobeNewswire - Tue Jan 12, 4:26PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it received written correspondence from The NASDAQ Stock Market LLC ("NASDAQ"
notifying Capnia that it now complies with the NASDAQ Capital Market continued listing standards.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Closes Second Tranche of Private Placement of Convertible Preferred Stock
GlobeNewswire - Mon Jan 11, 3:02PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has closed the $5.4 million second tranche of its previously-announced $10 million convertible preferred stock and warrant offering with funds managed by Sabby Management, LLC, collectively as the sole investor. Capnia closed the $4.6 million first tranche in October 2015.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Granted Orphan Designation for Nasal CO2 for the Treatment of Trigeminal Neuralgia
GlobeNewswire - Mon Dec 21, 6:00AM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the Company's nasal, non-inhaled carbon dioxide (nasal CO2) technology for the treatment of trigeminal neuralgia (TN).
CAPNU: (), CAPN: 1.00 (unch)
Capnia Reports Third Quarter 2015 Financial Results
GlobeNewswire - Thu Nov 12, 3:10PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the third quarter ended September 30, 2015.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Private Placement of Up to $10 Million of Convertible Preferred Stock and Warrants
GlobeNewswire - Mon Oct 12, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel diagnostic and therapeutic products based on its proprietary technologies for precision metering of gas flow, today announced that it has entered into an agreement with funds managed by Sabby Management, LLC, collectively as the sole investor, to purchase up to $10 million of Series A convertible preferred stock (the "Preferred Stock". The sale of the Preferred Stock is expected to take place in two separate closings. Upon the first closing, which is expected to occur on or about October 15, 2015, the Company will receive gross proceeds of approximately $4.6 million. Upon the successful completion of the second closing for up to $5.4 million, the full $10 million of Preferred Stock will be convertible into 5,405,406 shares of the Company's Common Stock, based on a fixed conversion price of $1.85 per share on an as-converted basis. In addition, the Company will issue Series D Warrants to purchase 2,702,703 shares of Common Stock, the number of shares exercisable pursuant to such Warrants, proportionate to the gross proceeds received by the Company at each closing.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Participate at Upcoming Investor Conferences
GlobeNewswire - Wed Sep 30, 3:01PM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced its participation in two upcoming investor conferences:
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Publication of CoSense(R) Clinical Data in the Journal Neonatology
GlobeNewswire - Thu Sep 24, 7:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced a paper, titled "Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis," has been published online in Neonatology (2016;109:1-5 [DOI:10.1159/000438482]). This peer-reviewed paper, which is expected to appear in the January 2016 print issue, discusses recent clinical research demonstrating the superiority of CoSense End-Tidal Carbon Monoxide (ETCO) Monitor at detecting hemolysis in jaundiced newborns.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Acquires Neonatal Pulmonary Resuscitation Solutions From NeoForce Group, Inc.
GlobeNewswire - Tue Sep 08, 6:00AM CDT
Acquisition Strengthens Capnia's Presence in Neonatology
CAPN: 1.00 (unch)
Capnia Announces $10 Million At-the-Market Firm Commitment Stock Purchase Agreement With Aspire Capital
GlobeNewswire - Mon Jul 27, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for precision metering of gas flow, today announced it has entered into a common stock purchase agreement with Aspire Capital Fund, LLC ("Aspire Capital". Under the new agreement, Capnia has the right to sell up to $10 million in value of its common stock to Aspire Capital, subject to certain terms and conditions, over a two-year period. The agreement represents a strategic tool that provides Capnia with important capital to fund the development of its therapeutics pipeline.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Present at Upcoming Investor Conferences
GlobeNewswire - Tue Sep 06, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at two upcoming investor conferences:
CAPNU: (), CAPN: 1.00 (unch)
Capnia Reports Second Quarter 2016 Financial Results
GlobeNewswire - Fri Aug 12, 3:05PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the second quarter ended June 30, 2016.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Exclusive Distribution Agreement for CoSense(R) End-Tidal Carbon Monoxide Monitor in India
GlobeNewswire - Tue Jun 07, 3:05PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has entered into an exclusive three-year distribution agreement with M/s.Healthware Private Limited (Healthware) for the sale of its CoSense End-Tidal Carbon Monoxide (ETCO) Monitor and Precision Sampling Sets in India.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Present at 2016 Marcum MicroCap Conference
GlobeNewswire - Wed May 25, 3:05PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the 2016 Marcum MicroCap Conference on Wednesday, June 1, 2016 at 11:30 AM ET at the Grand Hyatt in New York City.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Reports First Quarter 2016 Financial Results
GlobeNewswire - Tue May 10, 8:29AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the first quarter ended March 31, 2016.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Present at the Joseph Gunnar "Pioneers 2016" Conference
GlobeNewswire - Wed Apr 27, 3:06PM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the Joseph Gunnar "Pioneers 2016" Conference on Thursday, May 5, 2016 at 1:00 PM ET at the New York Palace Hotel in New York City.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Presentation of CoSense(R) and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting
GlobeNewswire - Wed Apr 20, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced five posters and one oral presentation relating to scientific data for its CoSense ETCO monitor and other pipeline candidates at the 2016 Pediatric Academic Societies (PAS) Annual Meeting, being held April 30 - May 3, 2016 in Baltimore, MD.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Names Rajen Dalal to Board of Directors
GlobeNewswire - Mon Apr 18, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced the appointment of Rajen Dalal to the Company's Board of Directors. Mr. Dalal brings to Capnia extensive leadership experience, having served as a senior executive and board member for various medical device and point-of-care diagnostic companies during his career. He most recently served as the CEO of ReLIA Diagnostic Systems, Inc., a point-of-care diagnostics company, and served on ReLIA's board from 2006 until its sale to Yunfeng Capital in 2015, and was managing director of Synergenics LLC, the company's majority shareholder.
CAPNU: (), CAPN: 1.00 (unch)
Capnia to Present at the 18th Annual BIO CEO & Investor Conference
GlobeNewswire - Mon Feb 01, 3:04PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the 18 Annual BIO CEO & Investor Conference on Monday, February 8, 2016 at 8:00 AM ET at the Waldorf Astoria Hotel in New York City.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Signs Exclusive Nationwide Distribution Agreement for CoSense(R)
GlobeNewswire - Tue Jan 26, 3:01PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has entered into an exclusive distribution agreement with Bemes, Inc., a leading medical equipment Master Distributor, to market and distribute the CoSense End-Tidal Carbon Monoxide (ETCO) Monitor and Precision Sampling Sets (PSS).
CAPNU: (), CAPN: 1.00 (unch)
Capnia Regains Compliance With NASDAQ Listing Standards
GlobeNewswire - Tue Jan 12, 4:26PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it received written correspondence from The NASDAQ Stock Market LLC ("NASDAQ"
notifying Capnia that it now complies with the NASDAQ Capital Market continued listing standards. CAPNU: (), CAPN: 1.00 (unch)
Capnia Closes Second Tranche of Private Placement of Convertible Preferred Stock
GlobeNewswire - Mon Jan 11, 3:02PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has closed the $5.4 million second tranche of its previously-announced $10 million convertible preferred stock and warrant offering with funds managed by Sabby Management, LLC, collectively as the sole investor. Capnia closed the $4.6 million first tranche in October 2015.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Granted Orphan Designation for Nasal CO2 for the Treatment of Trigeminal Neuralgia
GlobeNewswire - Mon Dec 21, 6:00AM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the Company's nasal, non-inhaled carbon dioxide (nasal CO2) technology for the treatment of trigeminal neuralgia (TN).
CAPNU: (), CAPN: 1.00 (unch)
Capnia Reports Third Quarter 2015 Financial Results
GlobeNewswire - Thu Nov 12, 3:10PM CST
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the third quarter ended September 30, 2015.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Private Placement of Up to $10 Million of Convertible Preferred Stock and Warrants
GlobeNewswire - Mon Oct 12, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel diagnostic and therapeutic products based on its proprietary technologies for precision metering of gas flow, today announced that it has entered into an agreement with funds managed by Sabby Management, LLC, collectively as the sole investor, to purchase up to $10 million of Series A convertible preferred stock (the "Preferred Stock"
. The sale of the Preferred Stock is expected to take place in two separate closings. Upon the first closing, which is expected to occur on or about October 15, 2015, the Company will receive gross proceeds of approximately $4.6 million. Upon the successful completion of the second closing for up to $5.4 million, the full $10 million of Preferred Stock will be convertible into 5,405,406 shares of the Company's Common Stock, based on a fixed conversion price of $1.85 per share on an as-converted basis. In addition, the Company will issue Series D Warrants to purchase 2,702,703 shares of Common Stock, the number of shares exercisable pursuant to such Warrants, proportionate to the gross proceeds received by the Company at each closing. CAPNU: (), CAPN: 1.00 (unch)
Capnia to Participate at Upcoming Investor Conferences
GlobeNewswire - Wed Sep 30, 3:01PM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced its participation in two upcoming investor conferences:
CAPNU: (), CAPN: 1.00 (unch)
Capnia Announces Publication of CoSense(R) Clinical Data in the Journal Neonatology
GlobeNewswire - Thu Sep 24, 7:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced a paper, titled "Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis," has been published online in Neonatology (2016;109:1-5 [DOI:10.1159/000438482]). This peer-reviewed paper, which is expected to appear in the January 2016 print issue, discusses recent clinical research demonstrating the superiority of CoSense End-Tidal Carbon Monoxide (ETCO) Monitor at detecting hemolysis in jaundiced newborns.
CAPNU: (), CAPN: 1.00 (unch)
Capnia Acquires Neonatal Pulmonary Resuscitation Solutions From NeoForce Group, Inc.
GlobeNewswire - Tue Sep 08, 6:00AM CDT
Acquisition Strengthens Capnia's Presence in Neonatology
CAPN: 1.00 (unch)
Capnia Announces $10 Million At-the-Market Firm Commitment Stock Purchase Agreement With Aspire Capital
GlobeNewswire - Mon Jul 27, 6:00AM CDT
Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for precision metering of gas flow, today announced it has entered into a common stock purchase agreement with Aspire Capital Fund, LLC ("Aspire Capital"
. Under the new agreement, Capnia has the right to sell up to $10 million in value of its common stock to Aspire Capital, subject to certain terms and conditions, over a two-year period. The agreement represents a strategic tool that provides Capnia with important capital to fund the development of its therapeutics pipeline. CAPNU: (), CAPN: 1.00 (unch)
